Towards Healthcare
U.S. Next Generation Sequencing Market to Grow 15.95% CAGR till 2035

U.S. Next Generation Sequencing Market Surges Amid Research Demand

Market insights predict, the U.S. next generation sequencing industry is expected to grow from USD 2.85 billion in 2025 to USD 12.52 billion by 2035, driven by a CAGR of 15.95%. The growing demand for personalized medicines and the increasing adoption of advanced technologies drive the market.

Content

  • Last Updated: 21 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The U.S. next generation sequencing market in 2026 is valued at USD 3.30 billion and is projected to climb to USD 12.52 billion by 2035, with a CAGR of 15.95% over the forecast period.

The U.S. next generation sequencing market includes 6 segments by product type, by application, by end-user, by sequencing type, by technology, and by region.

Some key players include Illumina, Inc., Thermo Fisher Scientific, and Ultima Genomics, Inc.

Key trends include the rising prevalence of genetic disorders, advancements in genomic technologies, and increasing investments.

NGS involves four basic steps extraction, library preparation, sequencing, and data analysis.

The NGS principle involves fragmenting the genetic material, preparing a library with adapters, and sequencing millions of fragments simultaneously.

National Institute of Health, Food and Drug Administration, National Cancer Institute, Centers for Disease Control and Prevention.
Any Questions